Insider Trades of ARCH VENTURE FUND VII LP Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date ▼ Type Tran OwnerType Shares Traded Last Price Shares Held
SYROS PHARMACEUTICALS, INC. Beneficial Owner (10%) 07/06/2016 Form 4 Acquisition (Non Open Market) direct 4,023,804 0 4,237,137
SYROS PHARMACEUTICALS, INC. Beneficial Owner (10%) 07/06/2016 Form 4 Buy direct 400,000 12.5 4,637,137
JUNO THERAPEUTICS, INC. Beneficial Owner (10%) 03/15/2016 Form 4 Disposition (Non Open Market) direct 1,000,000 0 10,552,390







Create your free portfolio




Most Rated Stocks of Last Week

Rated stocks for NASDAQ, NYSE and AMEX

Symbol / Ratings Consensus

AAPL 86% bullish of 2904 ratings Rate It

AMD 85% bullish of 179 ratings Rate It

F 83% bullish of 325 ratings Rate It

FB 76% bullish of 1323 ratings Rate It

NFLX 68% bullish of 323 ratings Rate It

TWTR 67% bullish of 207 ratings Rate It

BABA 77% bullish of 169 ratings Rate It

NVDA 83% bullish of 127 ratings Rate It

CAT 86% bullish of 80 ratings Rate It

BA 83% bullish of 71 ratings Rate It